DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Metabolomic signatures of chronic kidney disease of diverse etiologies in the rats and humans

Abstract

Chronic kidney disease (CKD) has emerged as a major public health problem worldwide. It frequently progresses to end-stage renal disease, which is related to very high cost and mortality. Novel biomarkers can provide insight into the novel mechanism, facilitate early detection, and monitor progression of CKD and its response to therapeutic interventions. To identify potential biomarkers, we applied an UPLC-HDMS together with univariate and multivariate statistical analyses using plasma samples from patients with CKD of diverse etiologies (100 sera in discovery set and 120 sera in validation set) and two different rat models of CKD. Using comprehensive screening and validation workflow, we identified a panel of seven metabolites that were shared by all patients and animals regardless of the underlying cause of CKD. These included ricinoleic acid, stearic acid, cytosine, LPA(16:0), LPA(18:2), 3-methylhistidine, and argininic acid. The combination of these seven biomarkers enabled the discrimination of patients with CKD from healthy subjects with a sensitivity of 83.3% and a specificity of 96.7%. In addition, these biomarkers accurately reflected improvements in renal function in response to the therapeutic interventions. Lastly, our results indicated that the identified biomarkers may improve the diagnosis of CKD and provide a novel tool for monitoring ofmore » the progression of disease and response to treatment in CKD patients.« less

Authors:
 [1];  [2];  [3];  [4];  [5];  [6];  [7]
  1. Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
  2. Northwest Univ., Shaanxi (China)
  3. Univ. of California, Irvine, CA (United States)
  4. Affiliated Hospital of Shaanxi Institute of Traditional Chinese Medicine, Shaanxi (China)
  5. Xi'an No. 4 Hospital. Shaanxi (China)
  6. Water Technologies (Shanghai) Ltd., Shanghai (China)
  7. Northwest Univ., Shaanxi (China); Univ. of California, Irvine, CA (United States)
Publication Date:
Research Org.:
Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
Sponsoring Org.:
USDOE Office of Science (SC)
OSTI Identifier:
1350944
Grant/Contract Number:  
AC05-00OR22725
Resource Type:
Accepted Manuscript
Journal Name:
Journal of Proteome Research
Additional Journal Information:
Journal Volume: 15; Journal Issue: 10; Journal ID: ISSN 1535-3893
Publisher:
American Chemical Society (ACS)
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; 5/6 nephrectomized rats; adenine-induced CKD rats; biomarker; chronic kidney disease; enalapril; irbesartan; metabolomics; plasma

Citation Formats

Zhang, Zhi -Hao, Chen, Hua, Vaziri, Nosratola D., Mao, Jia -Rong, Zhang, Li, Bai, Xu, and Zhao, Ying -Yong. Metabolomic signatures of chronic kidney disease of diverse etiologies in the rats and humans. United States: N. p., 2016. Web. doi:10.1021/acs.jproteome.6b00583.
Zhang, Zhi -Hao, Chen, Hua, Vaziri, Nosratola D., Mao, Jia -Rong, Zhang, Li, Bai, Xu, & Zhao, Ying -Yong. Metabolomic signatures of chronic kidney disease of diverse etiologies in the rats and humans. United States. https://doi.org/10.1021/acs.jproteome.6b00583
Zhang, Zhi -Hao, Chen, Hua, Vaziri, Nosratola D., Mao, Jia -Rong, Zhang, Li, Bai, Xu, and Zhao, Ying -Yong. Fri . "Metabolomic signatures of chronic kidney disease of diverse etiologies in the rats and humans". United States. https://doi.org/10.1021/acs.jproteome.6b00583. https://www.osti.gov/servlets/purl/1350944.
@article{osti_1350944,
title = {Metabolomic signatures of chronic kidney disease of diverse etiologies in the rats and humans},
author = {Zhang, Zhi -Hao and Chen, Hua and Vaziri, Nosratola D. and Mao, Jia -Rong and Zhang, Li and Bai, Xu and Zhao, Ying -Yong},
abstractNote = {Chronic kidney disease (CKD) has emerged as a major public health problem worldwide. It frequently progresses to end-stage renal disease, which is related to very high cost and mortality. Novel biomarkers can provide insight into the novel mechanism, facilitate early detection, and monitor progression of CKD and its response to therapeutic interventions. To identify potential biomarkers, we applied an UPLC-HDMS together with univariate and multivariate statistical analyses using plasma samples from patients with CKD of diverse etiologies (100 sera in discovery set and 120 sera in validation set) and two different rat models of CKD. Using comprehensive screening and validation workflow, we identified a panel of seven metabolites that were shared by all patients and animals regardless of the underlying cause of CKD. These included ricinoleic acid, stearic acid, cytosine, LPA(16:0), LPA(18:2), 3-methylhistidine, and argininic acid. The combination of these seven biomarkers enabled the discrimination of patients with CKD from healthy subjects with a sensitivity of 83.3% and a specificity of 96.7%. In addition, these biomarkers accurately reflected improvements in renal function in response to the therapeutic interventions. Lastly, our results indicated that the identified biomarkers may improve the diagnosis of CKD and provide a novel tool for monitoring of the progression of disease and response to treatment in CKD patients.},
doi = {10.1021/acs.jproteome.6b00583},
journal = {Journal of Proteome Research},
number = 10,
volume = 15,
place = {United States},
year = {Fri Sep 16 00:00:00 EDT 2016},
month = {Fri Sep 16 00:00:00 EDT 2016}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 61 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Ergosta-4,6,8(14),22-tetraen-3-one isolated from Polyporus umbellatus prevents early renal injury in aristolochic acid-induced nephropathy rats
journal, October 2011


Intra-Renal Angiotensin II/AT 1 Receptor, Oxidative Stress, Inflammation, and Progressive Injury in Renal Mass Reduction
journal, July 2007

  • Vaziri, N. D.; Bai, Y.; Ni, Z.
  • Journal of Pharmacology and Experimental Therapeutics, Vol. 323, Issue 1
  • DOI: 10.1124/jpet.107.123638

Ankaflavin: a natural novel PPARγ agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo
journal, December 2012


Lipotoxicity and Impaired High Density Lipoprotein-Mediated Reverse Cholesterol Transport in Chronic Kidney Disease
journal, September 2010


HDL abnormalities in nephrotic syndrome and chronic kidney disease
journal, November 2015


Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
journal, July 2013


Plasma Fatty Acids in Chronic Kidney Disease: Nervonic Acid Predicts Mortality
journal, March 2012

  • Shearer, Gregory C.; Carrero, Juan J.; Heimbürger, Olof
  • Journal of Renal Nutrition, Vol. 22, Issue 2
  • DOI: 10.1053/j.jrn.2011.05.005

Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy Trial
journal, December 2011

  • Evans, Marc; Bain, Stephen C.; Hogan, Simon
  • Nephrology Dialysis Transplantation, Vol. 27, Issue 6
  • DOI: 10.1093/ndt/gfr696

Intrarenal Metabolomic Investigation of Chronic Kidney Disease and its TGF-β1 Mechanism in Induced-adenine Rats using UPLC Q-TOF/HSMS/MS E
journal, January 2013

  • Zhao, Ying-Yong; Cheng, Xian-Long; Wei, Feng
  • Journal of Proteome Research, Vol. 12, Issue 2
  • DOI: 10.1021/pr3007792

Animal Model of Adenine-Induced Chronic Renal Failure in Rats
journal, January 1986

  • Yokozawa, Takako; Zheng, Ping Dong; Oura, Hikokichi
  • Nephron, Vol. 44, Issue 3
  • DOI: 10.1159/000183992

Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis
journal, September 2015

  • Zhang, Zhi-Hao; Wei, Feng; Vaziri, Nosratola D.
  • Scientific Reports, Vol. 5, Issue 1
  • DOI: 10.1038/srep14472

Renal expression of COX-2, ANG II, and AT 1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory
journal, May 2004

  • Gonçalves, Anderson Ricardo Roman; Fujihara, Clarice Kazue; Mattar, Ana Lúcia
  • American Journal of Physiology-Renal Physiology, Vol. 286, Issue 5
  • DOI: 10.1152/ajprenal.00238.2003

Soluble Urokinase Receptor and Chronic Kidney Disease
journal, November 2015

  • Hayek, Salim S.; Sever, Sanja; Ko, Yi-An
  • New England Journal of Medicine, Vol. 373, Issue 20
  • DOI: 10.1056/NEJMoa1506362

Chronic Kidney Disease and Mortality Risk: A Systematic Review
journal, May 2006

  • Tonelli, Marcello; Wiebe, Natasha; Culleton, Bruce
  • Journal of the American Society of Nephrology, Vol. 17, Issue 7
  • DOI: 10.1681/ASN.2005101085

Prevalence of Chronic Kidney Disease in the United States
journal, November 2007


Dialysis modality-dependent changes in serum metabolites: accumulation of inosine and hypoxanthine in patients on haemodialysis
journal, September 2010

  • Choi, J. -Y.; Yoon, Y. J.; Choi, H. -J.
  • Nephrology Dialysis Transplantation, Vol. 26, Issue 4
  • DOI: 10.1093/ndt/gfq554

Metabolomics – the link between genotypes and phenotypes
journal, January 2002


Metabolomics in the study of kidney diseases
journal, October 2011


The ins and outs of lysophosphatidic acid signaling
journal, January 2004

  • Moolenaar, Wouter H.; van Meeteren, Laurens A.; Giepmans, Ben N. G.
  • BioEssays, Vol. 26, Issue 8
  • DOI: 10.1002/bies.20081

An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure
journal, February 2016

  • Zhang, Zhi-Hao; Vaziri, Nosratola D.; Wei, Feng
  • Scientific Reports, Vol. 6, Issue 1
  • DOI: 10.1038/srep22151

A Pharmaco-Metabonomic Study on Chronic Kidney Disease and Therapeutic Effect of Ergone by UPLC-QTOF/HDMS
journal, December 2014


Dysfunctional fatty acid oxidation in renal fibrosis
journal, December 2014


Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease
journal, July 2009


Expression and Cellular Localization of Inducible Nitric Oxide Synthase in Lipopolysaccharide-treated Rat Kidneys
journal, January 2012

  • Choi, Jae-Youn; Nam, Sun-Ah; Jin, Dong-Chan
  • Journal of Histochemistry & Cytochemistry, Vol. 60, Issue 4
  • DOI: 10.1369/0022155411436131

Animal models of pediatric chronic kidney disease. Is adenine intake an appropriate model?
journal, November 2015


Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease
journal, June 2013

  • Ruiz, Stacey; Pergola, Pablo E.; Zager, Richard A.
  • Kidney International, Vol. 83, Issue 6
  • DOI: 10.1038/ki.2012.439

Normal and Pathologic Concentrations of Uremic Toxins
journal, May 2012

  • Duranton, Flore; Cohen, Gerald; De Smet, Rita
  • Journal of the American Society of Nephrology, Vol. 23, Issue 7
  • DOI: 10.1681/ASN.2011121175

Optimized Metabolomic Approach to Identify Uremic Solutes in Plasma of Stage 3–4 Chronic Kidney Disease Patients
journal, August 2013


Lysophosphatidic acid and renal fibrosis
journal, September 2008

  • Pradere, J.
  • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, Vol. 1781, Issue 9
  • DOI: 10.1016/j.bbalip.2008.04.001

Correction of acidosis in hemodialysis decreases whole-body protein degradation.
journal, April 1997

  • Graham, K. A.; Reaich, D.; Channon, S. M.
  • Journal of the American Society of Nephrology, Vol. 8, Issue 4
  • DOI: 10.1681/ASN.V84632

Works referencing / citing this record:

Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis
journal, March 2019


Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma
journal, September 2019


Lysophosphatidic Acid Signaling in Diabetic Nephropathy
journal, June 2019

  • Lee, Jong; Kim, Donghee; Oh, Yoon
  • International Journal of Molecular Sciences, Vol. 20, Issue 11
  • DOI: 10.3390/ijms20112850

Machine learning distilled metabolite biomarkers for early stage renal injury
journal, December 2019


Urinary metabolomics reveals the therapeutic effect of HuangQi Injections in cisplatin-induced nephrotoxic rats
journal, June 2017


Metabolomics for clinical use and research in chronic kidney disease
journal, March 2017


A review of validated biomarkers obtained through metabolomics
journal, June 2018

  • López-López, Ángeles; López-Gonzálvez, Ángeles; Barker-Tejeda, Tomás Clive
  • Expert Review of Molecular Diagnostics, Vol. 18, Issue 6
  • DOI: 10.1080/14737159.2018.1481391

Role of lysophosphatidic acid and its receptors in the kidney
journal, November 2017


Microbiome–metabolome reveals the contribution of gut–kidney axis on kidney disease
journal, January 2019

  • Chen, Yuan-Yuan; Chen, Dan-Qian; Chen, Lin
  • Journal of Translational Medicine, Vol. 17, Issue 1
  • DOI: 10.1186/s12967-018-1756-4

Toxicity and Its Mechanism Study of Arecae semen Aqueous Extract in Wistar Rats by UPLC-HDMS-Based Serum Metabolomics
journal, January 2020

  • Jia, Zhe; Han, Ting; Lin, Qinghua
  • Evidence-Based Complementary and Alternative Medicine, Vol. 2020
  • DOI: 10.1155/2020/2716325

Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease
journal, August 2017


New perspectives on CKD-induced dyslipidemia
journal, August 2017

  • Bermúdez-López, Marcelino; Arroyo, David; Betriu, Àngels
  • Expert Opinion on Therapeutic Targets, Vol. 21, Issue 10
  • DOI: 10.1080/14728222.2017.1369961

Tissue, urine and blood metabolite signatures of chronic kidney disease in the 5/6 nephrectomy rat model
journal, August 2019


PPAR α contributes to protection against metabolic and inflammatory derangements associated with acute kidney injury in experimental sepsis
journal, May 2019

  • Iwaki, Takuma; Bennion, Brock G.; Stenson, Erin K.
  • Physiological Reports, Vol. 7, Issue 10
  • DOI: 10.14814/phy2.14078

Microbiome–metabolome reveals the contribution of gut–kidney axis on kidney disease
journal, January 2019

  • Chen, Yuan-Yuan; Chen, Dan-Qian; Chen, Lin
  • Journal of Translational Medicine, Vol. 17, Issue 1
  • DOI: 10.1186/s12967-018-1756-4

Metabolomic Alterations Associated with Cause of CKD
journal, September 2017

  • Grams, Morgan E.; Tin, Adrienne; Rebholz, Casey M.
  • Clinical Journal of the American Society of Nephrology, Vol. 12, Issue 11
  • DOI: 10.2215/cjn.02560317

PPAR α contributes to protection against metabolic and inflammatory derangements associated with acute kidney injury in experimental sepsis
journal, May 2019

  • Iwaki, Takuma; Bennion, Brock G.; Stenson, Erin K.
  • Physiological Reports, Vol. 7, Issue 10
  • DOI: 10.14814/phy2.14078

Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis
journal, March 2019


Feline urine metabolomic signature: characterization of low-molecular-weight substances in urine from domestic cats
journal, February 2017

  • Rivera-Vélez, Sol-Maiam; Villarino, Nicolas F.
  • Journal of Feline Medicine and Surgery, Vol. 20, Issue 2
  • DOI: 10.1177/1098612x17701010

Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma
journal, September 2019


Microbiome–metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease
journal, May 2019

  • Feng, Ya-Long; Cao, Gang; Chen, Dan-Qian
  • Cellular and Molecular Life Sciences, Vol. 76, Issue 24
  • DOI: 10.1007/s00018-019-03155-9

Lysophosphatidic Acid Signaling in Diabetic Nephropathy
journal, June 2019

  • Lee, Jong; Kim, Donghee; Oh, Yoon
  • International Journal of Molecular Sciences, Vol. 20, Issue 11
  • DOI: 10.3390/ijms20112850